EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES

被引：0
作者：
Maher, T. [1 ,2 ]
Bonella, F. [3 ]
Assassi, S. [4 ]
Noth, I. [5 ]
Diefenbach, C. [6 ]
Ittrich, C. [7 ]
Rohr, K. [8 ]
Kolb, M. [9 ,10 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Duisburg Essen Univ, Ruhrlandklin Univ Hosp, Ctr Interstitial & Rare Lung Dis, Essen, Germany
[4] Univ Texas Houston, Div Rheumatol, McGovern Med Sch, Houston, TX USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
[6] Boehringer Ingelheim Pharma GmbH Co KG, Translat Med & Clin Pharmacol, Biberach, Germany
[7] Boehringer Ingelheim Pharma GmbH Co KG, Global Biostat & Data Sci, Biberach, Germany
[8] Boehringer Ingelheim Int GmbH, TA Inflammat Med, Ingelheim, Germany
[9] McMaster Univ, Div Respirol, Hamilton, NY USA
[10] St Josephs Healthcare, Div Respirol, Hamilton, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Clinical trials; Lungs; Biomarkers;
D O I：
10.1136/annrheumdis-2023-eular.1557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0845
引用
收藏
页码：722 / 722
页数：1
相关论文
共 43 条
  • [21] Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease
    Bao, Yunqi
    Zhang, Wei
    Shi, Dandan
    Bai, Weili
    He, Dongdong
    Wang, Dan
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2553 - 2560
  • [22] Efficacy and safety of oral versus intravenous cyclophosphamide in treatment of connective tissue disease-related interstitial lung disease
    Feng, Yuan
    Chen, Jia
    Yang, Xichao
    Liu, Jie
    Cao, Xue
    Zhang, Yan
    Wu, Zhenbiao
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (10)
  • [23] Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study
    Bauer, Philippe R.
    Kalra, Sanjay
    Osborn, Thomas G.
    St Sauver, Jennifer
    Hanson, Andrew C.
    Schroeder, Darrell R.
    Ryu, Jay H.
    [J]. RESPIRATORY MEDICINE, 2015, 109 (03) : 397 - 405
  • [24] Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis-Related Interstitial Lung Disease
    Kaenmuang, Punchalee
    Navasakulpong, Asma
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (04) : 312 - 320
  • [25] A Systematic Review on Biomarkers: Are There Reliable Molecular Biomarkers in Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease?
    Lira, Sheezara T.
    Costa, Maxsuel R.
    Barros, Wergila R. Gonsalves
    Goncalves Jr, Jucier
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [26] LUNG ULTRASOUND FOR THE FOLLOW-UP OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE TREATED WITH NINTEDANIB: OUTCOMES AND COMPARISONS WITH OTHER ASSESSMENT TOOLS
    Di Battista, M.
    Della Rossa, A.
    Da Rio, M.
    Romei, C.
    Delle Sedie, A.
    Mosca, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1015 - 1015
  • [27] CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): THREEYEAR DATA FROM SENSCIS-ON
    Allanore, Y.
    Vonk, M.
    Distler, O.
    Azuma, A.
    Mayes, M.
    James, A.
    Kohlbrenner, V.
    Alves, M.
    Khanna, D.
    Highland, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 281 - 281
  • [28] Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
    Y. Xu
    C. S. Yang
    Y. J. Li
    X. D. Liu
    J. N. Wang
    Q. Zhao
    W. G. Xiao
    P. T. Yang
    [J]. Clinical Rheumatology, 2016, 35 : 113 - 116
  • [29] Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
    Xu, Y.
    Yang, C. S.
    Li, Y. J.
    Liu, X. D.
    Wang, J. N.
    Zhao, Q.
    Xiao, W. G.
    Yang, P. T.
    [J]. CLINICAL RHEUMATOLOGY, 2016, 35 (01) : 113 - 116
  • [30] Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial
    Azuma, Arata
    Chung, Lorinda
    Behera, Digambar
    Chung, Melody
    Kondoh, Yasuhiro
    Ogura, Takashi
    Okamoto, Masaki
    Swarnakar, Rajesh
    Zeng, Xiaofeng
    Zou, Heijan
    Meng, Xianhua
    Gahlemann, Martina
    Alves, Margarida
    Kuwana, Masataka
    [J]. RESPIRATORY INVESTIGATION, 2021, 59 (02) : 252 - 259
12345